Efficacy and Safety of Subcutaneous Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Prior Intravenous Eculizumab: 2-Year Follow-upCaroline I. Piatek,Flore Sicre de Fontbrune,Fahri Sahin,Wolfgang Fuereder,Sandra Fatima Gualandro,Wilma Barcellini,Masayo Ogawa,Stephan Ortiz,Ayca Ozol-Godfrey,Jeff Szer,Mustafa YenerelBLOOD(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要